Biohaven Ltd.BHVNNYSE
LOADING
|||
| Metric | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 |
|---|---|---|---|---|---|
| Revenue Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Gross Profit Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EBITDA Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Income Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Net Income Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EPS Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EPS Diluted Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Weighted Average Shares Growth | +38.13% | +26.43% | +24.93% | +16.64% | +12.13% |
| Weighted Average Shares Diluted Growth | +38.13% | +26.43% | +24.93% | +16.64% | +12.13% |
| Dividends per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Cash Flow Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Free Cash Flow Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Receivables Growth | +0.00% | -80.40% | -100.00% | -100.00% | -100.00% |
| Inventory Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Asset Growth | +33.39% | +19.85% | +9.66% | -5.53% | -19.86% |
| Book Value per Share Growth | -21.12% | -21.74% | -31.09% | -69.93% | +0.00% |
| Debt Growth | -8.17% | +18.48% | +16.31% | +880.27% | +983.81% |
| R&D Expense Growth | +65.00% | +24.23% | +20.27% | -41.44% | -10.43% |
| SG&A Expenses Growth | +36.80% | +25.11% | +24.60% | +44.22% | +37.22% |